Citations 1
Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411
Parekh, Samir , Yang, David T. , Kostakoğlu, Lale , Baghdadi, Tareq Al, Maddocks, Kami J. , Romer, Mark D., Inwards, David J. , Lerner, Rachel E. , Little, Richard F. , Friedberg, Jonathan W. , Leonard, John P. , Parekh, Samir , Smith, Mitchell R. , Jegede, Opeyemi A. , Martin, Peter, Till, Brian G. , Casulo, Carla , Bartlett, Nancy L. , Caimi, Paolo F. , Wagner, Lynne I. , Kahl, Brad S.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 186-188
